Literature DB >> 19332333

Commentary: novel delivery approaches for antiepileptic drugs: hope and hurdles.

Dieter Schmidt1, Gregory L Holmes.   

Abstract

Mesh：

Substances：

Year:  2009        PMID： 19332333      PMCID： PMC5084217          DOI： 10.1016/j.nurt.2009.01.008

Source DB:  PubMed          Journal:  Neurotherapeutics        ISSN： 1878-7479            Impact factor:   7.620


× No keyword cloud information.
  4 in total

Review 1.  Drug resistance in epilepsy: putative neurobiologic and clinical mechanisms.

Authors:  Dieter Schmidt; Wolfgang Löscher
Journal:  Epilepsia       Date:  2005-06       Impact factor: 5.864

2.  Lasting blood-brain barrier disruption induces epileptic focus in the rat somatosensory cortex.

Authors:  Ernst Seiffert; Jens P Dreier; Sebastian Ivens; Ingo Bechmann; Oren Tomkins; Uwe Heinemann; Alon Friedman
Journal:  J Neurosci       Date:  2004-09-08       Impact factor: 6.167

3.  A randomised controlled trial examining the longer-term outcomes of standard versus new antiepileptic drugs. The SANAD trial.

Authors:  A G Marson; R Appleton; G A Baker; D W Chadwick; J Doughty; B Eaton; C Gamble; A Jacoby; P Shackley; D F Smith; C Tudur-Smith; A Vanoli; P R Williamson
Journal:  Health Technol Assess       Date:  2007-10       Impact factor: 4.014

4.  Multiple treatment comparisons in epilepsy monotherapy trials.

Authors:  Catrin Tudur Smith; Anthony G Marson; David W Chadwick; Paula R Williamson
Journal:  Trials       Date:  2007-11-05       Impact factor: 2.279
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.